SCHEMBL10594592

SCHEMBL10594592

CC(=O)N(CCNCC(O)COc1cccc2[nH]ccc12)SCCO[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 15/20 0.48
▸ ADRB2 P07550 5/20 0.48
▸ ADRB1 P08588 5/20 0.48
▸ HTR1A P08908 3/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ GLA P06280 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ DRD4 P21917 1/20 0.48
▸ HTR1B P28222 1/20 0.48
▸ HTR2C P28335 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10505338 0.89 ADRB3 (0.40) ADRB3ADRB2ADRB1HTR1ACYP3A4
SCHEMBL10593570 0.87 ADRB2 (0.47) ADRB3ADRB2ADRB1HTR1ACYP1A2
SCHEMBL10593257 0.85 ADRB3 (0.49) ADRB3ADRB2ADRB1HTR1ACYP1A2
SCHEMBL10593379 0.82 GRK3 (0.37) ADRB3ADRB2ADRB1CYP1A2MEN1
SCHEMBL10593454 0.81 ADRB1 (0.49) ADRB3ADRB2ADRB1HTR1ACYP1A2
SCHEMBL10504871 0.81 ADRB3 (0.49) ADRB3ADRB2ADRB1HTR1ACYP1A2
SCHEMBL10593380 0.81 ADRB1 (0.42) ADRB3ADRB2ADRB1HTR1ADRD4
SCHEMBL10592682 0.80 ADRB1 (0.51) ADRB3ADRB2ADRB1HTR1AOPRK1
SCHEMBL10593360 0.80 MEN1 (0.35) ADRB3ADRB2ADRB1CYP1A2CYP3A4
SCHEMBL10593229 0.80 KMT2A (0.34) ADRB3ADRB2ADRB1HTR1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 — — US disclosed
Send feedback